Amedisys Inc
Amedisys, Inc. provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment provides a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services,… Read more
Amedisys Inc (AMED) - Net Assets
Latest net assets as of June 2025: $1.27 Billion USD
Based on the latest financial reports, Amedisys Inc (AMED) has net assets worth $1.27 Billion USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.22 Billion) and total liabilities ($940.48 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.27 Billion |
| % of Total Assets | 57.55% |
| Annual Growth Rate | 23.05% |
| 5-Year Change | 45.54% |
| 10-Year Change | 187.49% |
| Growth Volatility | 102.05 |
Amedisys Inc - Net Assets Trend (1993–2024)
This chart illustrates how Amedisys Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Amedisys Inc (1993–2024)
The table below shows the annual net assets of Amedisys Inc from 1993 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $1.18 Billion | +5.37% |
| 2023-12-31 | $1.12 Billion | +1.19% |
| 2022-12-31 | $1.11 Billion | +13.34% |
| 2021-12-31 | $976.32 Million | +20.42% |
| 2020-12-31 | $810.74 Million | +26.38% |
| 2019-12-31 | $641.51 Million | +32.92% |
| 2018-12-31 | $482.63 Million | -6.54% |
| 2017-12-31 | $516.43 Million | +11.99% |
| 2016-12-31 | $461.14 Million | +12.35% |
| 2015-12-31 | $410.44 Million | +3.19% |
| 2014-12-31 | $397.76 Million | +6.79% |
| 2013-12-31 | $372.48 Million | -18.00% |
| 2012-12-31 | $454.23 Million | -12.67% |
| 2011-12-31 | $520.15 Million | -40.87% |
| 2010-12-31 | $879.72 Million | +19.47% |
| 2009-12-31 | $736.34 Million | +30.99% |
| 2008-12-31 | $562.12 Million | +25.52% |
| 2007-12-31 | $447.82 Million | +23.03% |
| 2006-12-31 | $364.01 Million | +89.00% |
| 2005-12-31 | $192.60 Million | +29.72% |
| 2004-12-31 | $148.47 Million | +188.86% |
| 2003-12-31 | $51.40 Million | +203.01% |
| 2002-12-31 | $16.96 Million | +402.76% |
| 2001-12-31 | $3.37 Million | +275.73% |
| 2000-12-31 | $-1.92 Million | +81.00% |
| 1999-12-31 | $-10.10 Million | +12.75% |
| 1998-12-31 | $-11.58 Million | -239.87% |
| 1997-12-31 | $8.28 Million | +83.88% |
| 1996-12-31 | $4.50 Million | +4.72% |
| 1995-12-31 | $4.30 Million | +95.45% |
| 1994-12-31 | $2.20 Million | +15.79% |
| 1993-12-31 | $1.90 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Amedisys Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 131759.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $791.16 Million | 69.73% |
| Common Stock | $38.00K | 0.00% |
| Other Components | $343.35 Million | 30.26% |
| Total Equity | $1.13 Billion | 100.00% |
Amedisys Inc Competitors by Market Cap
The table below lists competitors of Amedisys Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NH Investment & Securities Co Ltd
KO:005940
|
$3.26 Billion |
|
EASTERN BANKSHARES DL-01
F:EB0
|
$3.26 Billion |
|
Burberry Group plc
PINK:BBRYF
|
$3.26 Billion |
|
CyberAgent Inc
F:CL2
|
$3.26 Billion |
|
HORIBA Ltd
F:01H
|
$3.25 Billion |
|
Sandstorm Gold Ltd N
NYSE:SAND
|
$3.25 Billion |
|
Kingsemi Co Ltd
SHG:688037
|
$3.25 Billion |
|
Itissalat Al-Maghrib (IAM) S.A
PINK:MAOTF
|
$3.25 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Amedisys Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,066,514,000 to 1,134,541,000, a change of 68,027,000 (6.4%).
- Net income of 43,231,000 contributed positively to equity growth.
- Share repurchases of 6,152,000 reduced equity.
- Other factors increased equity by 30,948,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $43.23 Million | +3.81% |
| Share Repurchases | $6.15 Million | -0.54% |
| Other Changes | $30.95 Million | +2.73% |
| Total Change | $- | 6.38% |
Book Value vs Market Value Analysis
This analysis compares Amedisys Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.94x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 66.44x to 2.94x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1993-12-31 | $1.52 | $100.99 | x |
| 1994-12-31 | $1.42 | $100.99 | x |
| 1995-12-31 | $1.77 | $100.99 | x |
| 1996-12-31 | $1.26 | $100.99 | x |
| 1997-12-31 | $1.65 | $100.99 | x |
| 1998-12-31 | $-2.86 | $100.99 | x |
| 1999-12-31 | $-2.47 | $100.99 | x |
| 2000-12-31 | $-0.33 | $100.99 | x |
| 2001-12-31 | $0.31 | $100.99 | x |
| 2002-12-31 | $1.41 | $100.99 | x |
| 2003-12-31 | $3.83 | $100.99 | x |
| 2004-12-31 | $8.22 | $100.99 | x |
| 2005-12-31 | $9.05 | $100.99 | x |
| 2006-12-31 | $16.33 | $100.99 | x |
| 2007-12-31 | $17.01 | $100.99 | x |
| 2008-12-31 | $20.87 | $100.99 | x |
| 2009-12-31 | $26.48 | $100.99 | x |
| 2010-12-31 | $30.82 | $100.99 | x |
| 2011-12-31 | $18.08 | $100.99 | x |
| 2012-12-31 | $15.13 | $100.99 | x |
| 2013-12-31 | $11.91 | $100.99 | x |
| 2014-12-31 | $12.10 | $100.99 | x |
| 2015-12-31 | $12.40 | $100.99 | x |
| 2016-12-31 | $13.64 | $100.99 | x |
| 2017-12-31 | $15.02 | $100.99 | x |
| 2018-12-31 | $14.33 | $100.99 | x |
| 2019-12-31 | $19.41 | $100.99 | x |
| 2020-12-31 | $24.32 | $100.99 | x |
| 2021-12-31 | $28.25 | $100.99 | x |
| 2022-12-31 | $32.20 | $100.99 | x |
| 2023-12-31 | $32.72 | $100.99 | x |
| 2024-12-31 | $34.33 | $100.99 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Amedisys Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.81%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.84%
- • Asset Turnover: 1.10x
- • Equity Multiplier: 1.89x
- Recent ROE (3.81%) is below the historical average (9.32%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1993 | -5.26% | -0.71% | 3.26x | 2.26x | $-290.00K |
| 1995 | 20.93% | 2.39% | 3.27x | 2.67x | $470.00K |
| 1996 | 0.42% | 0.04% | 2.73x | 3.91x | $-413.16K |
| 1997 | -14.43% | -2.19% | 2.38x | 2.76x | $-2.02 Million |
| 1998 | 0.00% | -65.30% | 0.86x | 0.00x | $-23.70 Million |
| 1999 | 0.00% | 1.33% | 2.31x | 0.00x | $2.32 Million |
| 2000 | 0.00% | 7.02% | 2.18x | 0.00x | $6.56 Million |
| 2001 | 162.77% | 4.89% | 2.31x | 14.40x | $5.06 Million |
| 2002 | 4.43% | 0.58% | 2.22x | 3.44x | $-944.30K |
| 2003 | 16.36% | 5.90% | 1.54x | 1.80x | $3.27 Million |
| 2004 | 13.81% | 9.03% | 1.14x | 1.35x | $5.66 Million |
| 2005 | 15.63% | 7.89% | 1.12x | 1.77x | $10.84 Million |
| 2006 | 10.51% | 7.07% | 1.17x | 1.27x | $1.85 Million |
| 2007 | 14.57% | 9.33% | 1.19x | 1.31x | $20.42 Million |
| 2008 | 15.44% | 7.30% | 1.11x | 1.91x | $30.55 Million |
| 2009 | 18.48% | 8.98% | 1.29x | 1.59x | $62.32 Million |
| 2010 | 12.82% | 6.89% | 1.26x | 1.48x | $24.79 Million |
| 2011 | -73.71% | -26.01% | 1.71x | 1.65x | $-434.35 Million |
| 2012 | -18.48% | -5.62% | 2.04x | 1.62x | $-128.82 Million |
| 2013 | -25.84% | -7.70% | 1.72x | 1.95x | $-133.40 Million |
| 2014 | 3.22% | 1.06% | 1.80x | 1.69x | $-26.94 Million |
| 2015 | -0.74% | -0.24% | 1.87x | 1.67x | $-43.98 Million |
| 2016 | 8.10% | 2.59% | 1.96x | 1.60x | $-8.76 Million |
| 2017 | 5.88% | 1.98% | 1.89x | 1.58x | $-21.23 Million |
| 2018 | 24.78% | 7.18% | 2.32x | 1.49x | $71.19 Million |
| 2019 | 19.80% | 6.49% | 1.55x | 1.97x | $62.79 Million |
| 2020 | 22.69% | 8.86% | 1.32x | 1.94x | $102.69 Million |
| 2021 | 22.45% | 9.44% | 1.19x | 1.99x | $115.94 Million |
| 2022 | 11.28% | 5.34% | 1.12x | 1.88x | $13.45 Million |
| 2023 | -0.91% | -0.44% | 1.09x | 1.93x | $-116.40 Million |
| 2024 | 3.81% | 1.84% | 1.10x | 1.89x | $-70.22 Million |
Industry Comparison
This section compares Amedisys Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $226,453,179
- Average return on equity (ROE) among peers: -1.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Amedisys Inc (AMED) | $1.27 Billion | -5.26% | 0.74x | $3.26 Billion |
| Addus HomeCare Corporation (ADUS) | $175.08 Million | 7.77% | 0.53x | $1.74 Billion |
| agilon health Inc (AGL) | $470.95 Million | -55.24% | 2.68x | $161.08 Million |
| Airsculpt Technologies Inc (AIRS) | $83.53 Million | 12.63% | 1.40x | $17.33 Million |
| AMN Healthcare Services Inc (AMN) | $116.10 Million | 32.55% | 1.62x | $624.22 Million |
| American Shared Hospital Service (AMS) | $25.18 Million | -6.04% | 1.15x | $8.12 Million |
| American Oncology Network Inc. (AONC) | $70.71 Million | -7.84% | 4.30x | $112.23 Million |
| Ardent Health Partners, Inc. (ARDT) | $760.28 Million | -4.69% | 2.12x | $224.01 Million |
| Arem Pacific Corporation (ARPC) | $-60.56K | 0.00% | 0.00x | $246.12K |
| Astrana Health Inc (ASTH) | $336.31 Million | 7.67% | 0.46x | $1.07 Billion |